Ethyl 4-hydroxy-8-isopropyl-6,7-dimethoxy-2-naphthoate, 98%, 250mg

(S)-2-(6-Benzhydrylpyridin-2-yl)-4-(tert-butyl)-4,5-dihydrooxazole, 97% 99%ee, 1g

(R)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride, 97.0%, 250mg

(R)-1-Boc-3-Isopropylpiperazine, 95.0%, 1g

D(+)-glucose monohydrate, min. 99.5%, Ph.Eur., 10 kg, plastic packaging.

7-(3-Bromopropyl)-1,3-dimethyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione, 98%, 2.5g

2,6-Diisopropylphenylboronic acid, 95.0%, 1g

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID, 95.0%, 500mg

1-Hexyloxy-4-nitrobenzene>98.0%(GC)25g

2-Bromo-5-cyanothiazole, 98.0%, 5g

Ethyl 3-oxo-3-(tetrahydro-2H-pyran-4-yl)propanoate, 95.0%, 25g

1-BROMO-2-METHOXY-4-(METHYLSULFONYL)BENZENE, 95.0%, 5g

4-ethoxy-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg